Nexus AG (0FGL.L)
EUR 68.83
(0.34%)
EUR 68.83
(0.34%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.22 Million EUR | 273.06% |
| 2022 | 865 Thousand EUR | -48.85% |
| 2021 | 1.69 Million EUR | -17.19% |
| 2020 | 2.04 Million EUR | 399.27% |
| 2019 | 409 Thousand EUR | -23.69% |
| 2018 | 536 Thousand EUR | -6.62% |
| 2017 | 574 Thousand EUR | -52.21% |
| 2016 | 1.2 Million EUR | 70.11% |
| 2015 | 706 Thousand EUR | 19.86% |
| 2014 | 589 Thousand EUR | 108.13% |
| 2013 | 283 Thousand EUR | -31.64% |
| 2012 | 414 Thousand EUR | 206.67% |
| 2011 | 135 Thousand EUR | -10.6% |
| 2010 | 151 Thousand EUR | -10.65% |
| 2009 | 169 Thousand EUR | -39.43% |
| 2008 | 279 Thousand EUR | -11.71% |
| 2007 | 316 Thousand EUR | 1.28% |
| 2006 | 312 Thousand EUR | -41.79% |
| 2005 | 536 Thousand EUR | -21.29% |
| 2004 | 681 Thousand EUR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 3.13 Million EUR | -2.85% |
| 2024 Q2 | 4.18 Million EUR | 33.52% |
| 2024 Q3 | 4.09 Million EUR | -2.22% |
| 2023 Q4 | 3.22 Million EUR | -6.52% |
| 2023 Q2 | 3.81 Million EUR | 97.98% |
| 2023 FY | 3.22 Million EUR | 273.06% |
| 2023 Q3 | 3.45 Million EUR | -9.56% |
| 2023 Q1 | 1.92 Million EUR | 122.89% |
| 2022 Q1 | 2.2 Million EUR | 30.46% |
| 2022 Q2 | 1.17 Million EUR | -46.92% |
| 2022 Q3 | 1.08 Million EUR | -7.77% |
| 2022 Q4 | 865 Thousand EUR | -19.91% |
| 2022 FY | 865 Thousand EUR | -48.85% |
| 2021 Q3 | 3.02 Million EUR | 21.68% |
| 2021 FY | 1.69 Million EUR | -17.19% |
| 2021 Q4 | 1.69 Million EUR | -44.1% |
| 2021 Q1 | 3.74 Million EUR | 83.59% |
| 2021 Q2 | 2.48 Million EUR | -33.69% |
| 2020 Q1 | 474 Thousand EUR | 15.89% |
| 2020 Q2 | 352 Thousand EUR | -25.74% |
| 2020 Q3 | 818 Thousand EUR | 132.39% |
| 2020 FY | 2.04 Million EUR | 399.27% |
| 2020 Q4 | 2.04 Million EUR | 149.63% |
| 2019 Q2 | 590 Thousand EUR | -1.5% |
| 2019 Q1 | 599 Thousand EUR | 11.75% |
| 2019 FY | 409 Thousand EUR | -23.69% |
| 2019 Q4 | 409 Thousand EUR | -56.99% |
| 2019 Q3 | 951 Thousand EUR | 61.19% |
| 2018 FY | 536 Thousand EUR | -6.62% |
| 2018 Q1 | 604 Thousand EUR | 5.23% |
| 2018 Q2 | 822 Thousand EUR | 36.09% |
| 2018 Q3 | 778 Thousand EUR | -5.35% |
| 2018 Q4 | 536 Thousand EUR | -31.11% |
| 2017 Q1 | 869 Thousand EUR | -27.64% |
| 2017 Q2 | 852 Thousand EUR | -1.96% |
| 2017 Q3 | 826 Thousand EUR | -3.05% |
| 2017 Q4 | 574 Thousand EUR | -30.51% |
| 2017 FY | 574 Thousand EUR | -52.21% |
| 2016 Q4 | 1.2 Million EUR | -1.23% |
| 2016 Q2 | 881 Thousand EUR | -1.01% |
| 2016 Q1 | 890 Thousand EUR | 26.06% |
| 2016 FY | 1.2 Million EUR | 70.11% |
| 2016 Q3 | 1.21 Million EUR | 38.02% |
| 2015 FY | 706 Thousand EUR | 19.86% |
| 2015 Q3 | 880 Thousand EUR | 10.41% |
| 2015 Q1 | 971 Thousand EUR | 64.86% |
| 2015 Q2 | 797 Thousand EUR | -17.92% |
| 2015 Q4 | 706 Thousand EUR | -19.77% |
| 2014 Q3 | 448 Thousand EUR | 0.9% |
| 2014 Q4 | 589 Thousand EUR | 31.47% |
| 2014 Q2 | 444 Thousand EUR | 19.68% |
| 2014 Q1 | 371 Thousand EUR | 31.1% |
| 2014 FY | 589 Thousand EUR | 108.13% |
| 2013 Q3 | 527 Thousand EUR | 40.53% |
| 2013 Q4 | 283 Thousand EUR | -46.3% |
| 2013 FY | 283 Thousand EUR | -31.64% |
| 2013 Q2 | 375 Thousand EUR | 31.12% |
| 2013 Q1 | 286 Thousand EUR | -30.92% |
| 2012 Q2 | 400 Thousand EUR | -3.85% |
| 2012 Q3 | 597 Thousand EUR | 49.25% |
| 2012 Q1 | 416 Thousand EUR | 208.15% |
| 2012 Q4 | 414 Thousand EUR | -30.65% |
| 2012 FY | 414 Thousand EUR | 206.67% |
| 2011 FY | 135 Thousand EUR | -10.6% |
| 2011 Q2 | 618 Thousand EUR | 167.53% |
| 2011 Q1 | 231 Thousand EUR | 52.98% |
| 2011 Q4 | 135 Thousand EUR | -74.29% |
| 2011 Q3 | 525 Thousand EUR | -15.05% |
| 2010 Q2 | 187 Thousand EUR | 19.87% |
| 2010 FY | 151 Thousand EUR | -10.65% |
| 2010 Q4 | 151 Thousand EUR | -98.8% |
| 2010 Q3 | 12.55 Million EUR | 6616.04% |
| 2010 Q1 | 156 Thousand EUR | -7.69% |
| 2009 Q4 | 169 Thousand EUR | 0.0% |
| 2009 FY | 169 Thousand EUR | -39.43% |
| 2008 FY | 279 Thousand EUR | -11.71% |
| 2007 FY | 316 Thousand EUR | 1.28% |
| 2006 FY | 312 Thousand EUR | -41.79% |
| 2005 FY | 536 Thousand EUR | -21.29% |
| 2004 FY | 681 Thousand EUR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Cegedim SA | 9.2 Million EUR | 64.928% |
| Guerbet SA | 305.17 Million EUR | 98.943% |
| Bastide Le Confort Médical SA | 43.2 Million EUR | 92.531% |
| Revenio Group Oyj | 10.5 Million EUR | 69.267% |
| Drägerwerk AG & Co. KGaA | 657.88 Million EUR | 99.509% |
| Sartorius Aktiengesellschaft | 1.03 Billion EUR | 99.689% |
| LNA Santé SA | 148.29 Million EUR | 97.824% |
| Siemens Healthineers AG | 4.26 Billion EUR | 99.924% |
| Medios AG | 60.43 Million EUR | 94.661% |
| Equasens Société anonyme | 10.31 Million EUR | 68.712% |
| Stratec SE | 142.62 Million EUR | 97.737% |